A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
PH-10 is a formulation of rose bengal disodium (RB) for topical administration to the skin.
PH-10 is capable of undergoing photochemical reactions when activated by ambient light. This
phase 2 study will assess whether topical PH-10 applied once daily to mild, moderate or
severe areas of atopic dermatitis (including atopic eczema) may ameliorate inflammation of
the skin when activated by ambient light.